IN8BIO INC. - COMMON STOCK
0.3233
10-1月-25 16:45:00
15 分の遅延
株式
+0.0107
+3.42%
本日の幅
0.3058 - 0.3499
ISIN
N/A
ソース
NASDAQ
-
IN8bio Doses First Patient in Phase 2 Clinical Trial of INB-400 in Newly Diagnosed Glioblastoma
30 4 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
24 4 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio to Present at Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
16 4 2024 16:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio Announces New Preclinical Data for Gamma-Delta nsCAR-T Cell Therapy Platform at AACR 2024
09 4 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights
14 3 2024 16:00:00 提供 Nasdaq GlobeNewswire
-
05 3 2024 16:30:00 提供 Nasdaq GlobeNewswire
-
14 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals
04 1 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
11 12 2023 16:05:00 提供 Nasdaq GlobeNewswire
-
IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement
11 12 2023 09:00:47 提供 Nasdaq GlobeNewswire
-
IN8bio Appoints Dr. Corinne Epperly to Board of Directors
07 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
05 12 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
20 11 2023 07:00:00 提供 Nasdaq GlobeNewswire
-
IN8bio Reports Third Quarter 2023 Financial Results and Provides Corporate Update
09 11 2023 16:00:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
03 11 2023 12:00:00 提供 Nasdaq GlobeNewswire
-
02 11 2023 09:17:21 提供 Nasdaq GlobeNewswire
-
IN8bio to Participate at the 2023 Truist Securities BioPharma Symposium
01 11 2023 08:00:01 提供 Nasdaq GlobeNewswire